Browsing by Keyword : Antiviral Agents
Showing results 27 to 41 of 41
| Pub Year | | Title | Author(s) |
| 2012 | | Learning from HSV-infected mice as a model of Behçet's disease | 손성향, 이은소 |
| 2015 | | Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis. | 정재연 |
| 2010 | | Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance. | 고경현, 이명희, 정재연, 조성원 |
| 2020 | | Management of liver diseases during the pandemic of coronavirus disease-19 | 김순선 |
| 2021 | | Molecular perspectives of SARS-CoV-2: Pathology, immune evasion, and therapeutic interventions | SHAH, MASAUD, 우현구 |
| 2013 | | Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population. | 정재연, 조성원 |
| 2013 | | Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy. | 김순선, 정재연, 조성원 |
| 2010 | | Outcomes of palivizumab prophylaxis for respiratory syncytial virus infection in preterm children with bronchopulmonary dysplasia at a single hospital in Korea from 2005 to 2009. | 박문성 |
| 2020 | | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | 김순선, 정재연 |
| 2022 | | Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry study | 김봉완 |
| 2015 | | Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea. | 이장훈 |
| 2012 | | Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody | 권명희 |
| 2015 | | Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance. | 김순선, 신성재, 유병무, 정재연, 조성원, 조효정 |
| 2022 | | Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment | 김영롱, 유진세, 허중연 |
| 2012 | | Viral genome RNA degradation by sequence-selective, nucleic-acid hydrolyzing antibody inhibits the replication of influenza H9N2 virus without significant cytotoxicity to host cells | 권명희 |
1
